With more than 200 patents and innovations among its founders, Genesis Innovations Group is a leader in medical device development and commercialization.
The cultivate(MD) model is already yielding a harvest, with multiple products entering the market.
Genesis Innovation Group is continuously seeking and investigating medical device technologies where our team can complement the creation of value. We are focused on early stage where our team can add value through addition of technical competence, talented team members, and financial resources.
Built on trust, with a long history of successful ventures
Jean Chaoui PhDCEO Genesis played an integral role in developing the strategy for my company. Together with additional investment of time, talent, and money by Genesis, Imascap has grown beyond my expectations.
Mike DeVriesChief Investment Officer Wakestream has invested along side Genesis in two of their portfolio companies because we have come to appreciate the depth of experience of the talent at Genesis and their highly innovative approach to business.
Stephen Gunther, MD I sought to leverage the value of my IP for years and struggled to get traction. Genesis engaged my project and within a year they did everything they said they would do, and the result was everything I hoped.
Chip CorriganCEO One of the best compliments I can say about Genesis is they have done every aspect of medical startup business, and succeeded at it, multiple times. Their professionalism throughout the vetting process was so far superior to any other group we had worked with. Genesis’ unique approach to investing comes from wearing every hat in the process, allowing them to know exactly where you are, where you want to go, and how to get there. It has been a pleasure working with them.
Dr. Ryan RoederFounder and Inventor After being here (2019 The State of Spine Surgery Think Tank) I’m even more glad to have partnered with Genesis. Your connections, experience, and overall perspective is perfect.
Holland, Mich. – October 29, 2020 – Genesis Innovation Group’s cultivate(MD) Capital Fund II LP, a fund focused on investments into early-stage healthcare companies with innovative technologies, announces that one …
Company Prepares MIRA for Use in Minimally-Invasive Laparoscopic Colon Surgery Holland, Mich. – October 28, 2020 – Genesis Innovation Group’s cultivate(MD) Capital Fund II LP, a fund focused on investments …
Holland, Mich., July 08, 2020 — HAPPE Spine announces that it has received notice of allowance from the U.S. Patent and Trademark Office for patent claims providing broad protections for …
